CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-13 | LLOYD RONALD K. President and CEO | Conversion · Series A Convertible Preferred Stock | −111,788 | 0 | ||
| 2020-10-07 | Riebman Jerome Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +30,412 | 30,412 | ||
| 2020-10-07 | Riebman Jerome Chief Medical Officer | Grant or award · Restricted Stock Units | +10,186 | 10,186 | ||
| 2020-10-07 | LLOYD RONALD K. President and CEO | Grant or award · Stock Option (Right to Buy) | +181,783 | 181,783 | ||
| 2020-10-07 | LLOYD RONALD K. President and CEO | Grant or award · Restricted Stock Units | +100,425 | 100,425 | ||
| 2020-10-07 | Ferguson Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +81,800 | 81,800 | ||
| 2020-10-07 | Englese Thomas Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +33,488 | 33,488 | ||
| 2020-10-07 | Englese Thomas Chief Commercial Officer | Grant or award · Restricted Stock Units | +13,890 | 13,890 | ||
| 2020-10-07 | Roberts Darryl EVP, Operations & Product Deve | Grant or award · Stock Option (Right to Buy) | +50,083 | 50,083 | ||
| 2020-10-07 | Roberts Darryl EVP, Operations & Product Deve | Grant or award · Restricted Stock Units | +11,112 | 11,112 |
Page 17 of 17 · 330 trades